Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in CADL — Candel Therapeutics, Inc.

CIK 886982 NEW YORK, NY
Back to CADL Full portfolio

Position in CADL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,143,724
+$2,028,872 QoQ
Shares Held
305,216
+34.1% QoQ
Ownership
0.399%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 138 holders
Holding Since
Dec 2021
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CADL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. CADL ranks #213 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,481,761 $1,232,765,138
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,163,191 $725,296,113
3 ROIV
Roivant Sciences Ltd.
 18,556,458 $656,713,046
4 TECH
BIO-TECHNE Corp
 7,343,324 $518,805,838
5 RVMD
Revolution Medicines, Inc.
 2,133,101 $399,487,154
6 MRNA
Moderna, Inc.
 4,671,950 $327,176,656
7 TNGX
Tango Therapeutics, Inc.
 9,980,620 $311,994,180
8 INCY
Incyte Corp
 2,305,782 $261,383,446

All Filings in CADL

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,143,724 305,216
2026-03-31 $1,114,852 227,521
2025-12-31 $367,729 65,085
2025-09-30 $183,706 36,021
2025-06-30 $401,789 79,405
2025-03-31 $308,862 54,666
2024-12-31 $566,247 65,236
2024-09-30 $209,708 30,261
2024-06-30 $112,995 18,225
2022-06-30 $32,519 10,037
2022-03-31 $53,495 10,510
2021-12-31 $82,837 10,593